Houston companies need to get ready for an artificial intelligence and machine learning revolution

The future is now

Houston's DataCon can help prepare business leaders for the digital revolution in AI and machine learning. Getty Images

Looming on the horizon is a data tsunami coming towards us at breakneck speed. Companies have worked hard to keep up, creating digital transformation, taking manual processes from desktops, clipboards, and the paper paradigm to the Cloud. We're now sitting on huge quantities of idle bits of information called dark data. It's over collected and unused data that has the potential power to create decision-making brilliance.

Business leaders are attempting to optimize siloed data – unrelated data collected in databases and spreadsheets or obsolete apps, to make critical decisions. We currently connect these siloes with other systems using a data processing step called ETL – Extract, Transform and Load. Take the data from one place, transform it so it can relate to another data resource and then load that data to another place for analysis. It's a big, time consuming, intermediary step we have figured out how to circumvent. "NoETL" technology is the next-generation magic wand of machine thinking and it's a game-changer.

As non-technical business leaders, we rely on our partners in IT to give us meaningful data that charts our course. They've been our faithful navigators. We've made the recommended investment in IT infrastructure and technology and counted on receiving analytics that will result in winning outcomes. It's now time to sit down at the table and have new conversations with IT leadership around AI.

A tectonic shift

We are now in a new place. AI has come upon us quickly and the promise of ROI is great. There are new technologies that give business leaders advantages never before realized. Data science is the new crystal ball to the future of business. Automation and machine learning are taking historical data to a look ahead using algorithms and mathematical modeling. It's a new predictive mindset. What business leader wouldn't want that crystal ball?

The real assets of your business exist not in better machines but in your current data stores which are like coal mines waiting for data science to turn those lumps of coal into data diamonds.

There are new vocabulary words associated with data analytics. Data science thought leaders are preparing the way for businesses to have learning opportunities and to know which resources to tap for direction in creating new competitive dynamics. Don't wait too long to be curious. The early adopters are already a step ahead and the competitive marketplace is changing in unexpected ways.

Leadership resources for the implementation of AI

Legacy businesses with data lakes are ripe for action. Who should lead the charge? It's up to the C-suite to have intentional conversations around data science. It's up to leadership to be ready to speak and understand new concepts and vocabulary combined with leaps of faith needed to join the new world order of information.

Learning resources 

Proactively look for learning opportunities. There are no excuses for not taking the initiative. No matter where you are in your career – this isn't something to linger about.

One upcoming seminar around AI and automation collaboration and education is DataCon Houston. It's an annual conference that brings important concepts around AI and Automation to business leaders. The target audience is not IT professionals, although there will be some in attendance; it's meant primarily to help the C-suite and non-technical leaders know where to begin and where to find that new vocabulary and translative resources. AI will affect every person in every business, and we must be ready for the cultural shifts that will come with the technological shifts.

Authors and thought leaders — George Danner, Dave McComb, and Gerald Kane will be speaking at DataCon October 10, 2019. In addition, Javier Fadul, director of innovation for HTX Labs will be speaking about XR and data visualization and its use in training employees and creating safer workplaces. Stefanos Damianakis will be teaching machine learning 101 and Juan Sequeda, principal scientist of data.world will present his UltraWrap NoETL patented technology.

Solving the unsolvable

The future of decision-making will render in blinks of an eye. Problems we thought unsolvable will suddenly have answers. Business leaders must get behind the leap of faith required for our own companies and push learning and understanding forward across the organization at all levels. AI and machine learning are the vortex of change. Are you ready for AI?

------

Suzette Cotto is CEO of Innovate Social Media, a digital marketing agency specializing marketing for startups in the medical, technology, and energy industries. For more information on DataCon Houston 2019, please visit: https://incitelogix.com/datacon-houston-2019/

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings